Cargando…
Can YKL-40 be used as a biomarker for interstitial lung disease?: A systematic review and meta-analysis
BACKGROUND: Interstitial lung disease (ILD) has a poor prognosis and lacks specific biomarkers for early diagnosis, assessment of disease severity, and prognosis. YKL-40 levels were found to be elevated in patients with ILD, but these results are inconsistent. Therefore, we conducted a systematic re...
Autores principales: | Tong, Xiang, Ma, Yao, Liu, Tao, Li, Zhenzhen, Liu, Sitong, Wu, Guihui, Fan, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083999/ https://www.ncbi.nlm.nih.gov/pubmed/33907118 http://dx.doi.org/10.1097/MD.0000000000025631 |
Ejemplares similares
-
The YKL-40 protein is a potential biomarker for COPD: a meta-analysis and systematic review
por: Tong, Xiang, et al.
Publicado: (2018) -
IgG4-related lung disease presenting as interstitial lung disease with bronchiolitis: A case report
por: Chen, Chiu-Fan, et al.
Publicado: (2017) -
Characteristics and intrasubject variation in the respiratory microbiome in interstitial lung disease
por: Cho, Jun Yeun, et al.
Publicado: (2022) -
A case report of nilotinib-induced irreversible interstitial lung disease
por: Cho, Jun Yeun, et al.
Publicado: (2022) -
Utility of lung ultrasound to identify interstitial lung disease: An observational study based on the STROBE guidelines
por: Yan, Jun-Hong, et al.
Publicado: (2021)